Profile
Biography
Han-I is a research fellow in the York Trial Unit (YTU). She completed her Doctorate in health economics at the University of York in 2011 and worked in the Epidemiology Cancer Statistics Group (ECSG) (2011-2019) and the Mental Health and Addiction Research Group (MHARG) (2019-2023) before joining YTU in 2023.
Han-I specialises in economic evaluation, health outcome research and decision modelling. Her main research interests revolve around economic evaluation in the domains of cancers, mental health conditions, and chronic diseases, using large and complex patient-level data and cohort or patient-level simulation techniques. She is currently exploring the potential application of machine learning in the realm of economic evaluation and health outcome research. Han-I works closely with academic research teams and government bodies, both within and outside the University, to further her research objectives.
Qualifications
- PhD, Health Economics, University of York
- MSc, Health Economics (with distinction) Taipei Medical University
Departmental roles
- Deputy Programme Lead- PGCert in Health Research and Statistics
Research
Overview
Han-I is interested in health outcome research and economic evaluation with a particular emphasis on maximizing health benefits and equity. Her specific areas of research interest encompass cancer, mental health conditions, tobacco use, and chronic diseases such as diabetes. Her research interests include:
- Economic evaluation and health outcome research using complex patient level data
- Decision modelling/simulation research using real-world data
- Applications of machine learning in economic evaluation
- Patient treatment pathway research
- End-of-life care and place of death research
Projects
Research group(s)
Supervision
Han-I would be interested in supervising or co-supervising Masters and PhD students in the following areas: economic evaluation, cost analysis, health outcome research, decision modelling, big data analysis and machine learning, specifically focusing on cancer and mental health conditions.
External activities
Memberships
- Member of International Society for Pharmacoeconomics and Outcomes Research (2012 onwards)
- Member of the End-of-life and Palliative Care Steering Group Committee (2014)
Teaching involvement outside the University of York
• Statistics, Ravensbourne University London (Guest lecturer)
Editorial duties
- Member of the editorial board for the Pharmacoeconomics journal (2021 - present)
- Reviewer for NIHR grants (2014 – present)
Invited talks and conferences
Invited Talks/Seminars
- 11/2022 Oral presentation, ISPOR Europe Conference, Austria: Cost and effectiveness of one session treatment (OST) for children and young people with specific phobias compared to multi-session cognitive behavioural therapy (CBT)
- 05/2021 Invited speaker, China: Advanced decision modeling in health economical evaluation
- 01/2020 Four-day Workshop, Brazil: Discrete event simulation for HTA
- 11/2019 Two-day short course, Tianjin University, China: Essentials of Market access & challenges in Health economics
- 09/2019 Invited speaker, Taipei Medical University, Taiwan: Advanced decision modeling in health economical evaluation
- 07/2019 Seminar, The National Institute for Health and Care Excellence (NICE), London, UK: ’Use of real world evidence in NICE Guideline development’
- 10/2018 Seminar, Centre of Health Economics (CHE), University of York, UK: Generic economic evaluation model for follicular lymphoma: predicting treatment cost, life expectancy and quality-adjusted-life-year for different scenarios using UK population based observational data’
- 09/2018 Workshop, 11th ISPOR Asia Pacific Conference: ‘Bridging the gap between efficacy and effectiveness: using both real-world and trial-based evidence to improve clinical decision making’
- 08/2018 Workshop, Peking University National School of Development, China: ‘Economic analysis of large medical databases’
- 09/2017 Seminar, Taipei Medical University, Taiwan : A generic economic evaluation model for follicular lymphoma: predicting treatment cost, life expectancy and quality adjusted life year for different scenarios using UK population based observational data’
- 09/2016 Invited speaker, Taipei Medical University, Taiwan: NHS in the UK
- 01/2016 Invited speaker, Bocconi University, Italy: Discrete event simulation
- 09/2015 Invited spears, National Health Insurance Administration, Taiwan: Decision modelling
- 01/2014 Invited speaker, National Health Insurance Administration, Taiwan: Health Technology Assessment (HTA) in the UK
- 01/2014 Invited speaker, National Institute of Health Technology Assessment, Taiwan: Micro-costing methods
- 05/2013 Workshop, Taipei Medical University, Taiwan: Constructing Markov model in Excel
- 05/2013 Invited speaker, Taipei Medical University, Taiwan: Long-term medical costs and life expectancy of acute myeloid leukaemia
- 11/2012 Invited speaker, University of Oslo, Norway: Decision modelling in excel, using “long-term medical costs and life expectancy of acute myeloid leukaemia" as an example
Conferences
- 21st ISPOR Annual International Meeting (May 2016)
- 18th ISPOR Annual European Congress (Nov 2015): poster award
- 17th ISPOR Annual European Congress (Nov 2014)
- 16th ISPOR Annual European Congress (Nov 2013)
- 15th ISPOR Annual European Congress (Nov 2012)
- 5th ISPOR Asia Pacific Conference 2012 (Sep 2012)
